# Fernando Caravaca‐Fontán

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/fernando-caravaca-fontan/

## Facts

| Field | Value |
| --- | --- |
| Citations | 2,834 |
| Field | Renal Diseases and Glomerulopathies |
| h-index | 27 |
| i10-index | 57 |
| Last Known Institution | Research Institute Hospital 12 de Octubre |
| OpenAlex ID | https://openalex.org/A5048685325 |
| ORCID iD | 0000-0002-5830-9663 |
| Works | 180 |

## Researcher papers

- [The STARMEN trial indicates that alternating treatment with corticosteroids and cyclophosphamide is superior to sequential treatment with tacrolimus and rituximab in primary membranous nephropathy](https://scholariq.org/papers/the-starmen-trial-indicates-that-alternating-treatment-with-corticosteroids-and/)
- [A meta-analysis of GFR slope as a surrogate endpoint for kidney failure](https://scholariq.org/papers/a-meta-analysis-of-gfr-slope-as-a-surrogate-endpoint-for-kidney-failure/)
- [Duration of Treatment with Corticosteroids and Recovery of Kidney Function in Acute Interstitial Nephritis](https://scholariq.org/papers/duration-of-treatment-with-corticosteroids-and-recovery-of-kidney-function-in/)
- [Mayo Clinic consensus report on membranous nephropathy: proposal for a novel classification](https://scholariq.org/papers/mayo-clinic-consensus-report-on-membranous-nephropathy-proposal-for-a-novel/)
- [Severe and malignant hypertension are common in primary atypical hemolytic uremic syndrome](https://scholariq.org/papers/severe-and-malignant-hypertension-are-common-in-primary-atypical-hemolytic/)
- [Mycophenolate Mofetil in C3 Glomerulopathy and Pathogenic Drivers of the Disease](https://scholariq.org/papers/mycophenolate-mofetil-in-c3-glomerulopathy-and-pathogenic-drivers-of-the-disease/)
- [SARS-CoV-2 Infection in Hospitalized Patients With Kidney Disease](https://scholariq.org/papers/sars-cov-2-infection-in-hospitalized-patients-with-kidney-disease/)
- [Update on C3 Glomerulopathy: A Complement-Mediated Disease](https://scholariq.org/papers/update-on-c3-glomerulopathy-a-complement-mediated-disease/)
- [Targeting complement in IgA nephropathy](https://scholariq.org/papers/targeting-complement-in-iga-nephropathy/)
- [A Personalized Update on IgA Nephropathy: A New Vision and New Future Challenges](https://scholariq.org/papers/a-personalized-update-on-iga-nephropathy-a-new-vision-and-new-future-challenges/)
- [Clinical Presentation, Treatment Patterns, Burden of Disease, and the Association of Proteinuria with Clinical Outcomes in C3 Glomerulopathy and Primary Immune Complex Membranoproliferative Glomerulonephritis: A Systematic Review](https://scholariq.org/papers/clinical-presentation-treatment-patterns-burden-of-disease-and-the-association/)
- [Real-World Patient Characteristics, Burden, and Quality of Life in C3 Glomerulopathy and Primary Immune Complex Membranoproliferative GN](https://scholariq.org/papers/real-world-patient-characteristics-burden-and-quality-of-life-in-c3/)

## Researcher topics

- [Renal Diseases and Glomerulopathies](https://scholariq.org/topics/renal-diseases-and-glomerulopathies/)
- [Complement system in diseases](https://scholariq.org/topics/complement-system-in-diseases/)
- [Amyloidosis: Diagnosis, Treatment, Outcomes](https://scholariq.org/topics/amyloidosis-diagnosis-treatment-outcomes/)
- [Chronic Kidney Disease and Diabetes](https://scholariq.org/topics/chronic-kidney-disease-and-diabetes/)
- [Vasculitis and related conditions](https://scholariq.org/topics/vasculitis-and-related-conditions/)

## Researcher university

- [Research Institute Hospital 12 de Octubre](https://scholariq.org/institutions/research-institute-hospital-12-de-octubre/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.